Table 3. Association between season-specific quintile of serum 25(OH)D at baseline and mortality among men diagnosed with prostate cancer, ATBC Study.
Season-Specific Quintile of Serum 25(OH)D | # Prostate Cancer Deaths | Person-Years | HR (95% CI)* | HR (95% CI)† |
---|---|---|---|---|
Q1 | 69 | 875 | 1.0 (ref) | 1.0 (ref) |
Q2 | 79 | 1,231 | 0.81 (0.59 – 1.12) | 0.84 (0.61 – 1.17) |
Q3 | 76 | 1,433 | 0.69 (0.50 – 0.96) | 0.71 (0.51 – 0.99) |
Q4 | 55 | 1,368 | 0.52 (0.37 – 0.75) | 0.54 (0.38 – 0.77) |
Q5 | 83 | 1,629 | 0.69 (0.50 – 0.95) | 0.72 (0.52 – 0.99) |
p-trend | 0.003 | 0.006 |
Adjusted for age at prostate cancer diagnosis
Adjusted for age at prostate cancer diagnosis, cigarettes smoked per day, physical activity, and family history of prostate cancer